Celularity Inc — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GX Acquisition Corp. (CELU)
CIK: 0001752828
Period of Report: 2021-07-16

Reporting Person: Dunn Keary (General Counsel & Business Dev)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-16	Stock Option (Right to Buy)	$2.1829	A	105207	Acquired	2031-07-16	Class A Common Stock (105207)	Direct
2021-07-16	Stock Option (Right to Buy)	$2.1829	A	279089	Acquired	2031-07-16	Class A Common Stock (279089)	Direct

Footnotes

F1: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.